BioCentury
ARTICLE | Clinical News

Helivax: Completed Phase Ib/II trial enrollment

September 18, 2000 7:00 AM UTC

Antex Biologics Inc. (ANX), Gaithersburg, Md. Product: Helivax Business: Infectious diseases Therapeutic category: Immune stimulation Target: Immune cells Description: Oral vaccine consisting of inact...